Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 2
2016 2
2017 4
2019 1
2020 4
2021 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

14 results
Results by year
Filters applied: . Clear all
Page 1
Impact of expert pathologic review of thymic epithelial tumours on diagnosis and management in a real-life setting: A RYTHMIC study.
Molina TJ, Bluthgen MV, Chalabreysse L, de Montpréville VT, de Muret A, Dubois R, Hofman V, Lantuejoul S, le Naoures C, Mansuet-Lupo A, Parrens M, Piton N, Rouquette I, Secq V, Girard N, Marx A, Besse B. Molina TJ, et al. Among authors: bluthgen mv. Eur J Cancer. 2021 Jan;143:158-167. doi: 10.1016/j.ejca.2020.11.011. Epub 2020 Dec 11. Eur J Cancer. 2021. PMID: 33316754 Review.
Systemic lupus erythematosus associated with thymoma: A fifteen-year observational study in France.
Noël N, Le Roy A, Hot A, Saadoun D, Lazaro E, Lévesque H, Le Gouellec N, Meaux-Ruault N, Nguyen T, Costedoat-Chalumeau N, Amieux B, Fontana A, De Gennes C, Fulpin J, Thomas PA, Bluthgen MV, Besse B, Lambotte O. Noël N, et al. Among authors: bluthgen mv. Autoimmun Rev. 2020 Mar;19(3):102464. doi: 10.1016/j.autrev.2020.102464. Epub 2020 Jan 7. Autoimmun Rev. 2020. PMID: 31917264
Outcomes of patients with non-small cell lung cancer and poor performance status treated with immune checkpoint inhibitors in the real-world setting.
Rizzo MM, Bluthgen MV, Recondo G, Naveira M, Perfetti A, Rizzi F, Kuzminin A, Faura V, Cerini M, Videla A, Silva C, Lupinacci L, Minatta N. Rizzo MM, et al. Among authors: bluthgen mv. Int J Clin Oncol. 2021 Jun;26(6):1057-1064. doi: 10.1007/s10147-021-01896-x. Epub 2021 Mar 14. Int J Clin Oncol. 2021. PMID: 33715058
Association of metastatic pattern and molecular status in stage IV non-small cell lung cancer adenocarcinoma.
Dormieux A, Mezquita L, Cournede PH, Remon J, Tazdait M, Lacroix L, Rouleau E, Adam J, Bluthgen MV, Facchinetti F, Tselikas L, Aboubakar F, Naltet C, Lavaud P, Gazzah A, Le Pechoux C, Lassau N, Balleyguier C, Planchard D, Besse B, Caramella C. Dormieux A, et al. Among authors: bluthgen mv. Eur Radiol. 2020 Sep;30(9):5021-5028. doi: 10.1007/s00330-020-06784-y. Epub 2020 Apr 23. Eur Radiol. 2020. PMID: 32323012
Prognostic value of HLA-A2 status in advanced non-small cell lung cancer patients.
Mezquita L, Charrier M, Faivre L, Dupraz L, Lueza B, Remon J, Planchard D, Bluthgen MV, Facchinetti F, Rahal A, Polo V, Gazzah A, Caramella C, Adam J, Pignon JP, Soria JC, Chaput N, Besse B. Mezquita L, et al. Among authors: bluthgen mv. Lung Cancer. 2017 Oct;112:10-15. doi: 10.1016/j.lungcan.2017.07.004. Epub 2017 Jul 29. Lung Cancer. 2017. PMID: 29191581
Osimertinib benefit in EGFR-mutant NSCLC patients with T790M-mutation detected by circulating tumour DNA.
Remon J, Caramella C, Jovelet C, Lacroix L, Lawson A, Smalley S, Howarth K, Gale D, Green E, Plagnol V, Rosenfeld N, Planchard D, Bluthgen MV, Gazzah A, Pannet C, Nicotra C, Auclin E, Soria JC, Besse B. Remon J, et al. Among authors: bluthgen mv. Ann Oncol. 2017 Apr 1;28(4):784-790. doi: 10.1093/annonc/mdx017. Ann Oncol. 2017. PMID: 28104619 Free article. Clinical Trial.
14 results